asymptomatic carotid artery stenosis
Recently Published Documents


TOTAL DOCUMENTS

290
(FIVE YEARS 65)

H-INDEX

29
(FIVE YEARS 3)

2021 ◽  
Vol 23 (Supplement_G) ◽  
Author(s):  
Gabriele Masini ◽  
Luna Gargani ◽  
Vinicio Napoli ◽  
Mirco Cosottini ◽  
Dante Chiappino ◽  
...  

Abstract Aims Doppler ultrasound (DUS), CT angiography (CTA), and contrast-enhanced MR angiography (CEMRA) are all recommended techniques to evaluate the significance of carotid artery stenosis, although they may give discordant results. Plaque ulcerations may be present, but their role is still controversial. We aimed at assessing the concordance and level of agreement, as well as the prevalence of characteristics related to plaque ulceration and association to patients’ characteristics among different imaging diagnostic techniques. Methods and results Sixty-one patients with unilateral asymptomatic carotid artery stenosis (40–60% detected by DUS), enrolled in the ongoing CAMP study were prospectively evaluated with CEMRA and CTA. The level of agreement was calculated by the weighed kappa test. Plaque ulceration was defined as an intimal defect larger than 1 mm in width or 2 mm in depth, detected by CTA and/or CEMRA. Concordance rate was 71% for DUS–CTA, 51% for DUS–CEMRA, and 66% for CTA–CEMRA. Concordance among all noninvasive techniques was only 45%. Compared with DUS, the stenosis was downgraded by CTA in 17% and by CEMRA in 32% of cases. There was a moderate agreement between DUS–CTA {weighed kappa 0.49 [95% confidence interval (CI): 0.31–0.67]}, while agreement between DUS–CEMRA and CTA–CEMRA was fair [weighed kappa 0.15 (95% CI: −0.01–0.31) and 0.38 (95% CI: 0.14–0.62), respectively]. An ulcerated plaque was present in 39% of patients at CTA and/or CEMRA; compared with patients with non-ulcerated plaques, those with an ulcerated plaque had higher levels of C-reactive protein (CRP), and a trend to higher levels of high sensitivity cardiac troponin (cTn) T (Table), whereas the degree of stenosis was similar. Conclusions CTA and CEMRA tend to report a lower degree of stenosis compared with DUS. Concordance and level of agreement was higher for DUS and CTA. Plaque ulceration is common and is associated with a significant higher level of systemic inflammation, as detected by CRP and, possibly, cTn.


2021 ◽  
Vol 74 (5) ◽  
pp. e430-e431
Author(s):  
Adnan Husein ◽  
Daniel Law ◽  
Mohammed Al-Omran ◽  
Douglas S. Lee ◽  
Graham Roche-Nagle ◽  
...  

2021 ◽  
Vol 3 (1) ◽  
Author(s):  
Tilman Reiff ◽  
Hans-Henning Eckstein ◽  
Ulrich Mansmann ◽  
Olav Jansen ◽  
Gustav Fraedrich ◽  
...  

Abstract Background Asymptomatic carotid artery stenosis (ACS) can be treated with carotid endarterectomy (CEA), carotid artery stenting (CAS), or best medical treatment (BMT) only. For all treatment options, optimization of vascular risk factors such as arterial hypertension, hyperlipidemia, smoking, obesity, and insufficient physical activity is essential. Data on adherence to BMT and lifestyle modification in patients with ACS are sparse. The subject of this investigation is the implementation and quality of risk factor adjustment in the context of a randomized controlled trial. Methods A total of 513 patients in the prematurely terminated, randomized, controlled, multicenter SPACE-2 trial (ISRCTN 78592017) were analyzed within one year after randomization into 3 groups (CEA, CAS, and BMT only) for implementation of prespecified BMT recommendations and lifestyle modifications. Measurement time points were the screening visit and visits after one month (D30), 6 months (M6), and one year (A1). Differences between groups and follow-up visits (FUVs) relative to the screening visit were investigated. Findings For all FUVs, a significant increase in statin medication (91% at A1; p < 0.0001) was demonstrated to be associated with a significant decrease (p < 0.01) in cholesterol levels (median 167 mg/dl at A1) and LDL cholesterol levels (median 93 mg/dl at A1). The lowest cholesterol levels were achieved by patients in the BMT group. Seventy-eight percent of all patients reached predefined target cholesterol levels (< 200 mg/dl), with significantly better rates in the BMT group (p = 0.036 at D30). Furthermore, a significant decrease in arterial blood pressure at all FUVs (p < 0.05) was associated with a significant increase in antihypertensive medication (96% at A1, p < 0.0001). However, only 28% of patients achieved the predefined treatment goal of a systolic blood pressure of ≤ 130 mmHg. Forty-two of a total of 100 smokers at the screening visit quit smoking within one year, resulting in a significant increase in nonsmokers at all FUVs (p < 0.0001). Recommended HbA1c levels (< 7%) were achieved in 82% without significant changes after one year. Only 7% of obese (BMI > 25) patients achieved sufficient weight reduction after one year without significant changes at all FUVs (median BMI 27 at A1; p = 0.1201). The BMT group showed significantly (p = 0.024) higher rates of adequate physical activity than the intervention groups. Furthermore, after one year, the BMT group showed a comparatively significantly better implementation of risk factor modification (77%; p = 0.027) according to the treating physician. Interpretation SPACE-2 demonstrated sustained improvement in the noninterventional management of vascular risk factors in patients treated in a clinical trial by general practitioners, internists and neurologists. The best implemented treatment targets were a reduction in cholesterol and HbA1c levels. In this context, a significant increase in statin use was demonstrated. Blood pressure control missed its target but was significantly reduced by intensification of antihypertensive medication. Patients on BMT only had better adjusted lipid parameters and were more physically active. However, all groups failed to achieve sufficient weight reduction. Due to insufficient patient recruitment, the results must be interpreted cautiously. Trial registration: ISRCTN Registry, ISRCTN78592017, Registered 16 June 2007, https://www.isrctn.com/search?q=78592017.


BMC Neurology ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Shihao He ◽  
Ran Duan ◽  
Ziqi Liu ◽  
Cai Zhang ◽  
Tian Li ◽  
...  

Abstract Background Asymptomatic carotid artery stenosis (aCAS) impairs haemodynamic and cognitive functions; however, the relationship between these changes and brain network connectivity remains largely unknown. This study aimed to determine the relationship between functional connectivity and neurocognition in patients with aCAS. Methods We compared functional status in 14 patients with aCAS and 15 healthy controls using resting state functional magnetic resonance imaging sequences. The subjects underwent a full range of neuropsychological tests and a graphical theoretical analysis of their brain networks. Results Compared with controls, patients with aCAS showed significant decline in neuropsychological functions, particularly short-term memory (word-memory, p = .046 and picture-memory, p = .014). Brain network connectivity was lower in patients with aCAS than in the controls, and the decline of functional connectivity in aCAS patients was mainly concentrated in the left and right inferior frontal gyri, temporal lobe, left cingulate gyrus, and hippocampus. Decreased connectivity between various brain regions was significantly correlated with impaired short-term memory. Patients with aCAS showed cognitive impairment independent of known vascular risk factors for vascular cognitive impairment. The cognitive defects were mainly manifested in the short-term memory of words and pictures. Conclusions This study is the first of its kind to identify an association between disruption of functional connections in left carotid stenosis and impairment of short-term memory. The findings suggest that alterations in network connectivity may be an essential mechanism underlying cognitive decline in aCAS patients. Clinical trial registration-URL Unique identifier: 04/06/2019, ChiCTR1900023610.


Sign in / Sign up

Export Citation Format

Share Document